Get the Stockscreener App
25.99
2.87%
-0.7379
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $25.99, with a volume of 3.42M.
It is down -2.87% in the last 24 hours and up +14.83% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$26.73
Open:
$26.47
24h Volume:
3.42M
Relative Volume:
0.50
Market Cap:
$13.44B
Revenue:
$11.32B
Net Income/Loss:
$-981.00M
P/E Ratio:
-13.31
EPS:
-1.9532
Net Cash Flow:
$714.00M
1W Performance:
-6.54%
1M Performance:
+14.83%
6M Performance:
+25.19%
1Y Performance:
+7.38%
1-Day Range:
$25.88
$26.47
1-Week Range:
$25.88
$28.02
52-Week Range:
$15.73
$30.00
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
26.00 | 13.82B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
391.20 | 139.37B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
182.07 | 49.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.61 | 35.89B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.21 | 32.38B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.69 | 31.36B | 29.14B | 1.07B | 1.05B | 1.1956 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Baxter International stock extends Q2 rally as guidance and peers highlight momentum - AD HOC NEWS
AMG National Trust Bank Invests $2.52 Million in Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
BAX|Baxter International Inc|Price:26.685|Chg%:-0.365 - TradingKey
Form 8K BAXTER INTERNATIONAL INC For: 14 August By Investing.com - Investing.com Nigeria
Baxter International interim CFO Anita Zielinski to resign in September By Investing.com - Investing.com India
Baxter International interim CFO Anita Zielinski to resign in September - Investing.com
Baxter International (NYSE:BAX) Raised to "Hold" at Zacks Research - MarketBeat
Baxter International stock edges lower as market digests recent rating and price recovery - AD HOC NEWS
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Deepa Abi Joins Baxter International as Vice President, Global Business Solutions - hrtoday.in
Form 8K BAXTER INTERNATIONAL INC For: 11 August By Investing.com - Investing.com Nigeria
Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Baxter International (NYSE:BAX) Stock Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Baxter International Inc. (BAX) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential and Price Dynamics - directorstalkinterviews.com
Join Class Action to Recover Losses from Baxter International, In - The National Law Review
Why Baxter (BAX) Is Up 5.3% After $500 Million Debt Tender And CFO Transition News - simplywall.st
DWS Health and Wellness Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Levi & Korsinsky Urges Baxter International, Inc. (BAX) Sharehold - The National Law Review
Baxter International Inc (BAX) Stock Down 3.6% -- Now Undervalued? GF Score: 67/100 - GuruFocus
Baxter International Announces Upcoming CFO Leadership Transition - The Globe and Mail
Interim CFO exit at Baxter International (NYSE: BAX) set for Sept 15 - Stock Titan
Baxter International Inc Announces Resignation of Anita Zielinski from Interim Chief Financial Officer, Effective as of September 15, 2026 - marketscreener.com
Baxter International Inc. Announces Cash Tender Offers - marketscreener.com
JPMorgan Adjusts Price Target on Baxter International to $26 From $19, Maintains Neutral Rating - marketscreener.com
Baxter International launches $500M cash tender offers for select long-dated notes - TradingView
Baxter International Inc. Stock Advances 7.4%, Outperforms Peers - webull.com
Baxter International Inc (BAX) Shares Surge 7.4% -- What GF Scor - GuruFocus
Baxter International Inc (BAX): A Closer Look Behind a 66 GF Sco - GuruFocus
UBS Raises Price Target on Baxter International to $28 From $25, Maintains Neutral Rating - marketscreener.com
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Opportunities with a 4.33% Potential Upside - DirectorsTalk Interviews
Baxter International Sees Unusually Large Options Volume (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Baxter International Is Maintained at Equal-Weight by Wells Fargo - Moomoo
Jefferies & Co Adjusts Baxter International Price Target to $27 From $18, Maintains Hold Rating - Moomoo
Deutsche Bank Adjusts Baxter International PT to $27 From $20, Maintains Hold Rating - Moomoo
Citigroup Upgrades Baxter International to Neutral From Sell, Adjusts Price Target to $28 From $17 - Moomoo
Baxter International (NYSE:BAX) Stock Rating Upgraded by Citigroup - MarketBeat
Baxter International Inc (BAX) Shares Surge 8.0% -- What GF Score of 64 Tells Investors - GuruFocus
Baxter International 2026: Revenue $2.96B, EPS $0.24— 10-Q Summary - TradingView
Baxter International Inc (BAX) (Q2 2026) Earnings Call Highlight - GuruFocus
BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract - TradingView
Baxter International Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Baxter Turnaround Efforts Continue Under New Management Team - Morningstar
Baxter (NYSE:BAX) Reports Upbeat Q2 CY2026, Stock Jumps 16.1% - StockStory
Baxter International's Q2 Adjusted Earnings Fall, Revenue Rises; Increases 2026 Guidance; Shares Rise Pre-Bell - marketscreener.com
Baxter: Q2 Earnings Snapshot - KVUE
Earnings Flash (BAX) Baxter International Inc. Posts Q2 Adjusted EPS $0.56 per Share, Vs. FactSet Est of $0.37 - Moomoo
Baxter International Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):